Liraglutide
FF 121/2015
Approved small_molecule completed
Quick answer
Liraglutide for Morbid Obesity is a Approved program (small_molecule) at Sana Biotechnology with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Sana Biotechnology
- Indication
- Morbid Obesity
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed